title: Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.
authors.affiliation: National Human Genome Research Institute, the Molecular Imaging Program, National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1851, USA. mgaygun@mail.nih.gov
authors.forename: Meral
authors.initials: M
authors.lastname: Gunay-Aygun
authors.forename: Ellis D
authors.initials: ED
authors.lastname: Avner
authors.forename: Robert L
authors.initials: RL
authors.lastname: Bacallao
authors.forename: Peter L
authors.initials: PL
authors.lastname: Choyke
authors.forename: Joseph T
authors.initials: JT
authors.lastname: Flynn
authors.forename: Gregory G
authors.initials: GG
authors.lastname: Germino
authors.forename: Lisa
authors.initials: L
authors.lastname: Guay-Woodford
authors.forename: Peter
authors.initials: P
authors.lastname: Harris
authors.forename: Theo
authors.initials: T
authors.lastname: Heller
authors.forename: Julie
authors.initials: J
authors.lastname: Ingelfinger
authors.forename: Frederick
authors.initials: F
authors.lastname: Kaskel
authors.forename: Robert
authors.initials: R
authors.lastname: Kleta
authors.forename: Nicholas F
authors.initials: NF
authors.lastname: LaRusso
authors.forename: Parvathi
authors.initials: P
authors.lastname: Mohan
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Pazour
authors.forename: Benjamin L
authors.initials: BL
authors.lastname: Shneider
authors.forename: Vicente E
authors.initials: VE
authors.lastname: Torres
authors.forename: Patricia
authors.initials: P
authors.lastname: Wilson
authors.forename: Colleen
authors.initials: C
authors.lastname: Zak
authors.forename: Jing
authors.initials: J
authors.lastname: Zhou
authors.forename: William A
authors.initials: WA
authors.lastname: Gahl
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001652:Bile Ducts / Q000378:metabolism; D015220:Calcium Channels / Q000378:metabolism; D002648:Child; D018450:Disease Progression; D015870:Gene Expression; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy / Q000453:epidemiology; D007686:Kidney Tubules, Distal / Q000378:metabolism; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D008103:Liver Cirrhosis / Q000151:congenital* / Q000453:epidemiology / Q000628:therapy*; D010641:Phenotype; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D017354:Point Mutation / Q000235:genetics; D017044:Polycystic Kidney, Autosomal Recessive / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy*; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D015220:Calcium Channels; C451750:PKHD1 protein, human; D011956:Receptors, Cell Surface; D010727:Phosphoric Diester Hydrolases